202116 set 2021 10:00 - 18:20
In recent years, the management of patients with liver-related diseases has been revolutionized by improvements in diagnostic techniques as well as by the availability of new therapeutic options. However, liver-related complications still represent a major burden affecting outcome and survival of patients with cirrhosis. Current efforts are concentrating towards the development of personalized management approaches and the optimization of diagnostic, therapeutic and surveillance algorithms. Finally, changing epidemiology of liver disease has completely modified challenges in managing patients in field practice, and is also expected to change the scenario of liver transplantation in the near future.
Therefore, the event will be focused on recent advances in the treatment of chronic viral hepatitis, but also on non-invasive diagnostic techniques, such as those to stage NAFLD, to measure liver stiffness and to improve HCC surveillance. Finally, hepatocellular carcinoma (HCC) and available treatment options, from liver transplantation to immunotherapy, will be discussed.